Spiro[piperidine-2,2'-adamantane] hydrchloride

ID: ALA473915

Chembl Id: CHEMBL473915

PubChem CID: 44562844

Max Phase: Preclinical

Molecular Formula: C14H24ClN

Molecular Weight: 205.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C1CCC2(NC1)C1CC3CC(C1)CC2C3.Cl

Standard InChI:  InChI=1S/C14H23N.ClH/c1-2-4-15-14(3-1)12-6-10-5-11(8-12)9-13(14)7-10;/h10-13,15H,1-9H2;1H

Standard InChI Key:  TWBAZEHCSNXHPG-UHFFFAOYSA-N

Associated Targets(non-human)

Grin1 Glutamate NMDA receptor (6467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
H2N2 subtype (35 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Influenza B virus (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDCK (10148 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 205.34Molecular Weight (Monoisotopic): 205.1830AlogP: 2.95#Rotatable Bonds:
Polar Surface Area: 12.03Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 11.02CX LogP: 2.76CX LogD: -0.33
Aromatic Rings: Heavy Atoms: 15QED Weighted: 0.64Np Likeness Score: 0.85

References

1. Kolocouris A, Spearpoint P, Martin SR, Hay AJ, López-Querol M, Sureda FX, Padalko E, Neyts J, De Clercq E..  (2008)  Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.,  18  (23): [PMID:18947998] [10.1016/j.bmcl.2008.10.003]

Source